Related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES
Thursday 11 October 2012
  • APEX Medical
  • Performance
    The company's stock price closed at NT$28.05 on the TSE on Thursday, June 21, 2018.
    The company has reported consolidated revenues of NT$177 million for May 2018, representing a 3.3% increase on month and 11.6% drop on year.
    For the first quarter of 2018, the company totaled NT$499 million in consolidated revenues, down 2.5% sequentially and up 6.4% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    22-Jun 48 38 1,346,650 27.90 28.30 27.90 28.30+0.25+0.89% 28.20 28.30
    21-Jun 132 90 3,711,749 28.10 28.25 27.90 28.05-0.05-0.18% 28.05 28.10
    20-Jun 132 78 3,721,550 28.30 28.45 28.00 28.10-0.20-0.71% 28.10 28.20
    19-Jun 47 43 1,339,174 28.50 28.60 28.20 28.30-0.45-1.57% 28.25 28.45
    15-Jun 69 44 1,977,900 28.80 28.80 28.50 28.75-0.05-0.17% 28.60 28.80
    14-Jun 54 37 1,547,300 28.70 28.80 28.60 28.80+0.00+0.00% 28.60 28.80
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, May 2017 - May 2018 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    May-18

    177

    3.3%

    (11.6%)

    848

    1.6%

    Apr-18

    171

    (15.3%)

    3.5%

    671

    5.7%

    Mar-18

    202

    42.3%

    0.7%

    499

    6.5%

    Feb-18

    142

    (8.3%)

    3.9%

    297

    10.8%

    Jan-18

    155

    (12.2%)

    18%

    155

    18%

    Dec-17

    177

    (2.2%)

    (12.7%)

    2,090

    5.1%

    Nov-17

    181

    16.5%

    8.6%

    1,913

    7.1%

    Oct-17

    155

    (7.4%)

    (0.7%)

    1,732

    6.9%

    Sep-17

    167

    (20.6%)

    22.2%

    1,577

    7.7%

    Aug-17

    211

    12.2%

    38%

    1,410

    6.2%

    Jul-17

    188

    6.4%

    34.3%

    1,199

    2.1%

    Jun-17

    176

    (11.9%)

    1%

    1,011

    (2.3%)

    May-17

    200

    20.9%

    16.4%

    835

    (2.9%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

    Apex: Consolidated revenues, 1Q17 - 1Q18 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    1Q-18

    499

    (2.5%)

    6.4%

    499

    6.4%

    4Q-17

    512

    (9.6%)

    (2.7%)

    2,089

    5%

    3Q-17

    566

    4.5%

    31.8%

    1,577

    7.7%

    2Q-17

    542

    15.6%

    3%

    1,011

    (2.3%)

    1Q-17

    469

    (10.8%)

    (7.8%)

    469

    (7.8%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 1Q17 - 1Q18 (NT$k)

    Item

    1Q-2018

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    Current assets

    1,270,535

    1,284,144

    1,308,761

    1,338,039

    1,233,710

    Intangible assets

    449,079

    445,378

    446,802

    420,386

    415,497

    Non-current assets

    1,291,462

    1,300,150

    1,304,102

    1,317,025

    1,273,566

    Assets

    2,561,997

    2,584,294

    2,612,863

    2,655,064

    2,507,276

    Current liabilities

    615,930

    674,839

    718,649

    804,349

    678,421

    Non-current liabilities

    302,156

    301,266

    297,752

    296,389

    295,241

    Liabilities

    918,086

    976,105

    1,016,401

    1,100,738

    973,662

    Stockholders' equity

    1,643,911

    1,608,189

    1,596,462

    1,554,326

    1,533,614

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

    Apex: Consolidated income statement, 1Q17 - 1Q18 (NT$k)

    Item

    1Q-2018

    4Q-2017

    3Q-2017

    2Q-2017

    1Q-2017

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    499,244

     

    0

     

     

     

     

     

    469,035

     

    Operating revenue

    499,244

    100%

    511,812

     

    566,344

    120.7%

    542,086

    115.6%

    469,035

    100%

    Gross profit (loss) from operations

    205,173

    41.1%

    212,357

    41.5%

    235,788

    50.3%

    246,958

    52.7%

    211,420

    45.1%

    Operating expenses

    172,443

    34.5%

    205,187

    40.1%

    196,531

    41.9%

    182,293

    38.9%

    170,935

    36.4%

    Operating income (loss)

    32,730

    6.6%

    7,170

    1.4%

    39,257

    8.4%

    64,665

    13.8%

    40,485

    8.6%

    Non-operating expenses and losses

    148

    0%

    5,585

    1.1%

    1,814

    0.4%

    -3,328

    -0.7%

    -3,882

    -0.8%

    Income from continuing operations before income tax

    32,878

    6.6%

    12,755

    2.5%

    41,071

    8.8%

    61,337

    13.1%

    36,603

    7.8%

    Net income (loss)

    23,678

    4.7%

    20,034

    3.9%

    22,938

    4.9%

    48,498

    10.3%

    26,213

    5.6%

    Diluted earnings per share (NT$)

    0.3

     

    0.2

     

    0.3

     

    0.5

     

    0.3

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, June 2018

  • APEX Medical full profile

Taiwan handsets – 1Q 2018

Taiwan LCD TVs – 1Q 2018

Taiwan LCD monitors – 1Q 2018

Global AP market, 2017-2021

Taiwan server shipment forecast and industry analysis, 2018

China AMOLED panel capacity expansion forecast, 2016-2020

© DIGITIMES Inc. All rights reserved.
Please do not republish, publicly broadcast or publicly transmit content from this website without written permission from DIGITIMES Inc. Please contact us if you have any questions.